ABCL · Forms 3, 4, 5
Insider trades at AbCellera Biologics Inc.
3 insiders bought $1.5M of AbCellera Biologics Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for AbCellera Biologics Inc. (ABCL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael R Hayden | Director | Buy | 53,613 | $10.64 | $570K | Form 4 | |
| John S. Montalbano | Director | Buy | 10,000 | $11.03 | $110K | Form 4 | |
| Andrew Booth | Chief Financial Officer | Buy | 37,200 | $10.32 | $384K | Form 4 | |
| Michael R Hayden | Director | Buy | 46,387 | $10.37 | $481K | Form 4 | |
| Michael R Hayden | Director | Gift | 50,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.